Richmond, VA – According to filings with the U.S. Securities and Exchange Commission, Phlow is raising $50,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Eric Edwards played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Phlow
Phlow Corporation (Phlow) is a public benefit pharmaceutical manufacturing company on a mission to reliably supply affordable, high-quality, essential medicines through U.S.-based advanced manufacturing processes. Phlow manufactures precursor chemical ingredients, Active Pharmaceutical Ingredients (API), and finished pharmaceutical products, domestically for essential medicines critical to the Nations healthcare. To help ensure the quality, safety, and affordability of pharmaceutical products of strategic importance to the United States, Phlow utilizes advanced manufacturing platforms, including continuous manufacturing, to provide essential medicines to its customers, health systems and government partners.

To learn more about Phlow, visit http://www.phlow-usa.com/

Contact:
Eric Edwards, President and Chief Executive Officer
804-207-4893
eedwards@phlow-usa.com
https://www.linkedin.com/in/ericedwards-phlowusa/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved